However, formulation approaches combining CUR with novel or existing compounds such as MTF, vitamin D, polyphenols, sirtuin- 1 activators, dipeptidyl peptidase- 4 inhibitors, and other polyphenols could address heterogenous features of PCOS more efficiently than individual drug therapy. Here, DPP4 is linked to polycystic ovary syndrome.